NxStage Medical Appoints New CFO

The finance team at NxStage Medical (NASDAQ: NXTM  ) has a new leader. The company announced it has named Matthew Towse to be its senior vice president and CFO. Making room for him is the man he replaces in both positions, Robert Brown, who will serve as president of the firm's kidney-care subsidiary.

This is not Towse's first CFO job. He occupied that position at privately held technology company Vette and at Fairchild Semiconductor (NASDAQ: FCS  ) . He also held several managerial posts at National Semiconductor, now a unit of Texas Instruments (NASDAQ: TXN  ) .

In the press release announcing the news, NxStage touted Towse's "extensive experience aligning the financial and business strategies of high-growth companies. As our new CFO, Matt's leadership will be important as we execute against our strategic growth initiatives."


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2511733, ~/Articles/ArticleHandler.aspx, 12/19/2014 1:46:35 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement